Medications
Canada's Ontario province says will sue opioid makers
Canada's most populous province of Ontario on Monday announced plans to sue opioid makers to recover health care costs related to the deadly addiction epidemic.
May 27, 2019
0
5
Page 4 - News tagged with street drugs
Other
Pfizer's Q1 net jumps 14 pct., sales just miss expectations
Pfizer posted slightly higher sales and a 14 percent jump in profit in the first quarter, thanks to lower restructuring costs and a much-lower tax rate, but its revenue still missed Wall Street expectations.
May 1, 2018
0
2
Medications
Mylan, like other generic drugmakers, feels the pricing pain
Mylan's second-quarter profit and revenue surged, but not as much as Wall Street had expected and the company is taking a more conservative view going forward because of "ongoing challenges and the uncertain U.S. regulatory ...
Aug 9, 2017
0
0
Medications
Cempra shares plummet ahead of FDA meeting on antibiotic
Shares of drugmaker Cempra Inc. plunged Wednesday after federal regulators raised concerns about potential liver toxicity risks with its closely watched experimental antibiotic.
Nov 2, 2016
0
0
Other
Gilead 1Q profit tumbles on slower hepatitis C drug sales
Gilead Science Inc.'s earnings tumbled more than 17 percent in the first quarter as steeper discounts and rebates on its blockbuster hepatitis C drugs cut into sales.
Apr 28, 2016
0
2
Medications
Teva to lift bid for Mylan: report
Israeli pharmaceutical giant Teva plans to increase its bid for rival Mylan and could announce the move as soon as this week, according to a US media report Monday.
Jul 6, 2015
0
11
HIV & AIDS
AIDS crisis brewing in Crimea and east Ukraine says UN
A lethal health crisis is brewing in Russian-annexed Crimea and war-torn eastern Ukraine, where injecting drug users have lost access to therapy to wean them off heroin, the UN's AIDS envoy said Wednesday.
Jan 21, 2015
0
4
Other
Indian drugs group eyes $5 bn Swedish deal
Indian group Sun Pharmaceutical Industries is in talks to buy leading Swedish drugmaker Meda AB in what could result in a $5 billion takeover, the Wall Street Journal reported on Friday.
May 31, 2013
0
0
Other
Sanofi earnings slashed in first quarter
(AP)—French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings.
May 2, 2013
0
0
Alzheimer's disease & dementia
Research spinoff ReXceptor gets license for Alzheimer's treatment
Case Western Reserve's Technology Transfer Office has granted an exclusive license of a novel Alzheimer's Disease (AD) treatment strategy to spinoff company ReXceptor Inc., which plans to initiate early-stage human clinical ...
Apr 25, 2013
0
0
